Literature DB >> 2547909

Reduced protein kinase C activity in ischemic spinal cord.

A Kochhar1, T Saitoh, J Zivin.   

Abstract

Protein phosphorylation was evaluated in a rabbit spinal cord ischemia model under conditions where cyclic AMP-dependent protein kinase (PK-A) and calcium/phospholipid-dependent protein kinase (PK-C) were activated. One hour of ischemia did not affect PK-A activity significantly; however, PK-C activity was reduced by more than 60%. In vitro phosphorylation of endogenous proteins by endogenous PK-C revealed that eight particulate and five cytosolic proteins showed stimulated phosphorylation by PK-C activators in control tissue, although this stimulation was virtually absent in ischemic samples. When control and ischemic particulate fractions were combined, the endogenous protein phosphorylation pattern under PK-C-activating conditions was similar to the ischemic sample, which suggests that inhibitory molecules may be present in the ischemic particulate fraction. In vitro phosphorylation of endogenous proteins under PK-A-activating conditions in ischemic tissue was similar to that in control tissue. The results suggest that the PK-C phosphorylation system is selectively impaired in ischemic spinal cord. In addition to reduced PK-C-dependent phosphorylation, an Mr 64,000 protein was phosphorylated in ischemic cytosolic samples, but not in control samples. The phosphorylation of the Mr 64,000 protein was neither PK-C-dependent nor PK-A-dependent. These altered phosphorylation reactions may play critical roles in neuronal death during the course of ischemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547909     DOI: 10.1111/j.1471-4159.1989.tb11797.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  The regional changes of the catalytic NOS activity in the spinal cord of the rabbit after repeated sublethal ischemia.

Authors:  J Pavel; N Lukácová; J Marsala; M Marsala
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

2.  Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion.

Authors:  I Saluja; M H O'Regan; D Song; J W Phillis
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

3.  Calcium-dependent protein kinase C activation in acutely isolated neurons during oxygen and glucose deprivation.

Authors:  Geir Arne Larsen; Jon Berg-Johnsen; Morten C Moe; Morten Larsen Vinje
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

4.  The vulnerability of nitrergic neurons to transient spinal cord ischemia: a quantitative immunohistochemical and histochemical study.

Authors:  Andrea Schreiberová; Alexandra Kisucká; Ludmila Hricová; Andrea Kucharíková; Jaroslav Pavel; Nadežda Lukáčová
Journal:  J Mol Histol       Date:  2012-01-07       Impact factor: 2.611

Review 5.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

6.  Specific induction of protein kinase C delta subspecies after transient middle cerebral artery occlusion in the rat brain: inhibition by MK-801.

Authors:  S Miettinen; R Roivainen; R Keinänen; T Hökfelt; J Koistinaho
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

7.  Expression of protein kinase C in postischemic brain: an in situ hybridization study.

Authors:  K Kumar; S Savithiry; B Madhukar
Journal:  Metab Brain Dis       Date:  1992-06       Impact factor: 3.584

8.  Post-ischemic changes in protein kinase C RNA in the gerbil brain following prolonged periods of recirculation: a phosphorimaging study.

Authors:  K Kumar; X L Wu
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

9.  Isoflurane inhibits protein kinase Cgamma and calcium/calmodulin dependent protein kinase ii-alpha translocation to synaptic membranes in ischemic mice brains.

Authors:  Shohei Matsumoto; Michihiro Murozono; Daisuke Nagaoka; Shuhei Matsuoka; Akiko Takeda; Hideyuki Narita; Seigo Watanabe; Atsushi Isshiki; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.